#402 ‒ NMR blood analysis: how heart disease risk, insulin resistance, inflammation, and mortality risk can be assessed from a single blood sample | Jim Otvos, Ph.D.

Episode 402

0:00-2:25:14
60%

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Jim Otvos is a biophysical chemist who pioneered the use of nuclear magnetic resonance (NMR) spectroscopy to measure lipoprotein particles and developed the first FDA-cleared method for directly quantifying LDL particle number (LDL-P), a technology that has since expanded to provide broader insights into metabolic health, inflammation, insulin resistance, and mortality risk. In this episode, Jim recounts the unlikely story of transforming a flawed cancer test into a new way of measuring lipoproteins, explains what standard cholesterol tests can miss and why LDL-P and apoB can inform treatment decisions beyond LDL cholesterol alone, and dispels the misconception that large, "fluffy" LDL particles are benign. He also explores how NMR can reveal insulin resistance before blood sugar rises, GlycA as a marker of chronic low-grade inflammation, and the metabolic vulnerability index (MVX) as a potential measure of frailty, resilience, and mortality risk across the lifespan. Finally, Jim explains why NMR diagnostics remain underused despite the wealth of information they can extract from a single blood test.

Publisher

The Peter Attia Drive

Link

peterattiamd.com/jimotvos/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=260803-pod-gayatridevi&utm_content=260803-pod-jimotvos-podfeed

Published

August 3, 2026

Duration

2h 25m

Format

Podcast

Category

Lifestyle · Health & Wellness

Source

RSS feed

Host

Peter Attia, MD

TP

The Peter Attia Drive

@peterattiadrive

#nmrbloodanalysis #heartdiseaserisk #singlebloodsample

The Nile